Navigation Links
GPCRs in Drug Discovery - Efforts to De-Orphanize Novel GPCR Targets are Increasing
Date:10/25/2011

1 98

Figure 43: GPCRs in Drug Discovery, Schizophrenia, Comparison of Major Targets with Stage of Development, 2011 99

Figure 44: GPCRs in Drug Discovery, Obesity, Number of Molecules Targeting GPCRs By Phase, 2011 100

Figure 45: GPCRs in Drug Discovery, Obesity, Major Targets for Pipeline Molecules, 2011 101

Figure 46: GPCRs in Drug Discovery, Obesity, Comparison of Major Targets with Stage of Development, 2011 102

Figure 47: GPCRs in Drug Discovery, Hypertension, Number of Molecules Targeting GPCRs By Phase, 2011 103

Figure 48: GPCRs in Drug Discovery, Hypertension, Major Targets for Pipeline Molecules, 2011 104

Figure 49: GPCRs in Drug Discovery, Hypertension, Comparison of Major Targets with Stage of Development, 2011 105

Figure 50: GPCRs in Drug Discovery, Asthma, Number of Molecules Targeting GPCRs By Phase, 2011 106

Figure 51: GPCRs in Drug Discovery, Asthma, Major Targets for Pipeline Molecules, 2011 107

Figure 52: GPCRs in Drug Discovery, Asthma, Comparison of Major Targets with Stage of Development, 2011 108

Figure 53: GPCRs in Drug Discovery, Prostate Cancer, Number of Molecules Targeting GPCRs By Phase, 2011 109

Figure 54: GPCRs in Drug Discovery, Prostate Cancer, Major Targets for Pipeline Molecules, 2011 110

Figure 55: GPCRs in Drug Discovery, Prostate Cancer, Comparison of Major Targets with Stage of Development, 2011 111

Figure 56: GPCRs in Drug Discovery, COPD, Number of Molecules Targeting GPCRs By Phase, 2011 112

Figure 57: GPCRs in Drug Discovery, COPD, Major Targets for Pipeline Molecules, 2011 113

Figure 58: GPCRs in Drug Discovery, COPD, Comparison of Major Targets with Stage of Development, 2011 114

Figure 59: GPCRs in Drug Discovery, Glaucoma, Number of Molecules Targeting GPCRs By Phase, 2011 115

Figure 60: GPCRs in Drug Discovery, Glaucoma, Major Targets for Pipeline Molecules, 2011 116

Figure 61: GPCRs in Dr
'/>"/>

SOURCE Reportlinker
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14

Related medicine technology :

1. Omeros Unlocks Four Additional Orphan GPCRs
2. Omeros Unlocks Orphan GPCRs Linked to Leukemia and Sleep Disorders
3. Omeros Unlocks Orphan GPCRs Linked to Pancreatic Cancer and Cognitive Disorders
4. The Future of GPCRs in Drug Discovery: Novel Technologies, Leading Companies, and Opportunities for Target Expansion
5. Omeros Successfully Unlocks Orphan GPCRs
6. MUSC Dedicates New Bioengineering and Drug Discovery Hubs
7. SomaLogic Announces Research Agreement with Leading Global Pharmaceutical Company to Accelerate Pharmaceutical Discovery and Development
8. Karyopharm Therapeutics Inc. and Katholieke Universiteit Leuven Sign Exclusive Collaboration for the Discovery of Novel CRM1/Exportin 1 Inhibitors
9. Argos Therapeutics Late Scientific Co-founder Ralph Steinman, M.D., Awarded Nobel Prize in Medicine for Discovery of Dendritic Cells as Critical Sentinels of Immune System
10. St. Jude Childrens Research Hospital Discovery Aided Quest for Adult Cancer Drug
11. Discovery Labs Notified of PDUFA Date for SURFAXIN®
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/17/2013)... , May 17, 2013  Boehringer Ingelheim ... respiratory disease at the American Thoracic Society International ... , May 17 – 22. ... approved for the treatment of chronic obstructive pulmonary ... as well as investigational compounds for asthma, idiopathic ...
(Date:5/17/2013)... May 17, 2013  Sanofi (EURONEXT: SAN and NYSE: ... JAKARTA , examining the selective JAK2 ... in both dose groups. The primary endpoint assessed the ... Consistent with data reported in previous trials, the most ... Full results will be presented at an upcoming medical ...
(Date:5/17/2013)... , May 17, 2013  Boston Scientific Corporation (NYSE: ... the annual EuroPCR Scientific Program May 21-24 in ... to present a particularly rich and diversified set of ... Dawkins , M.D., global chief medical officer, Boston ... be presented, including the NG PROMUS trial, which evaluated ...
Breaking Medicine Technology:Boehringer Ingelheim to Present 17 Abstracts at the Annual American Thoracic Society International Conference 2Boehringer Ingelheim to Present 17 Abstracts at the Annual American Thoracic Society International Conference 3Boehringer Ingelheim to Present 17 Abstracts at the Annual American Thoracic Society International Conference 4Boehringer Ingelheim to Present 17 Abstracts at the Annual American Thoracic Society International Conference 5Boehringer Ingelheim to Present 17 Abstracts at the Annual American Thoracic Society International Conference 6Boehringer Ingelheim to Present 17 Abstracts at the Annual American Thoracic Society International Conference 7Boehringer Ingelheim to Present 17 Abstracts at the Annual American Thoracic Society International Conference 8Sanofi Reports Positive Topline Results from Pivotal Phase III JAKARTA Study for JAK2 Inhibitor in Myelofibrosis 2Sanofi Reports Positive Topline Results from Pivotal Phase III JAKARTA Study for JAK2 Inhibitor in Myelofibrosis 3Sanofi Reports Positive Topline Results from Pivotal Phase III JAKARTA Study for JAK2 Inhibitor in Myelofibrosis 4Sanofi Reports Positive Topline Results from Pivotal Phase III JAKARTA Study for JAK2 Inhibitor in Myelofibrosis 5Sanofi Reports Positive Topline Results from Pivotal Phase III JAKARTA Study for JAK2 Inhibitor in Myelofibrosis 6Boston Scientific Schedule of Major Events and Presentations at EuroPCR 2013 2Boston Scientific Schedule of Major Events and Presentations at EuroPCR 2013 3Boston Scientific Schedule of Major Events and Presentations at EuroPCR 2013 4Boston Scientific Schedule of Major Events and Presentations at EuroPCR 2013 5Boston Scientific Schedule of Major Events and Presentations at EuroPCR 2013 6Boston Scientific Schedule of Major Events and Presentations at EuroPCR 2013 7Boston Scientific Schedule of Major Events and Presentations at EuroPCR 2013 8
... 2011 Sigma-Aldrich Corporation (NASDAQ: SIAL ) ... unit, SAFC® ( www.safcglobal.com ), is introducing a novel ... (CHO) cell line. Designed for use in the production ... the first commercially available glutamine synthetase (GS) knockout CHO ...
... YORK, Oct. 27, 2011 Reportlinker.com ... report is available in its catalogue: ... Reimbursement Outlook: Optimizing price and market ... http://www.reportlinker.com/p0165652/Pharma-Pricing-and-Reimbursement-Outlook-Optimizing-price-and-market-access-in-a-recessionary-climate.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Health_Insurance ...
Cached Medicine Technology:SAFC Introduces the First Commercially Available Novel CHOZN® GS Knockout CHO Cell Line 2SAFC Introduces the First Commercially Available Novel CHOZN® GS Knockout CHO Cell Line 3SAFC Introduces the First Commercially Available Novel CHOZN® GS Knockout CHO Cell Line 4Pharma Pricing and Reimbursement Outlook: Optimizing price and market access in a recessionary climate 2Pharma Pricing and Reimbursement Outlook: Optimizing price and market access in a recessionary climate 3Pharma Pricing and Reimbursement Outlook: Optimizing price and market access in a recessionary climate 4Pharma Pricing and Reimbursement Outlook: Optimizing price and market access in a recessionary climate 5
(Date:5/18/2013)... CA (PRWEB) May 18, 2013 6Webs.com ... The simple to read reviews and comprehensive comparisons make ... impartial home security reviews. 6Webs.com just recently finished conducting ... system providers. , Tim Smythe from 6Webs.com reports, "There ... systems due to their ease of use, expandability and ...
(Date:5/18/2013)... 2013 The Ayurvedic practitioner program will ... in the West. Program is available in Mexico via ... a healing modality practiced for over 5,000 years. In ... that health begins when an individual lives in harmony ... individual needs. Ayurveda aims to heal an individual in ...
(Date:5/18/2013)... IL (PRWEB) May 18, 2013 The ... Oregon Gov. John A. Kitzhaber, M.D., (D) to sign ... law by prohibiting minors under the age of 18 ... would become the third state in the nation to ... have enacted similar indoor tanning bans for minors. Nationwide, ...
(Date:5/18/2013)... Stow, Ohio (PRWEB) May 18, 2013 ... 40th Annual Conference, on May 17-22 in Austin, ... associates gather for educational and networking opportunities. ... cleaning brushes, flexible scope repair capabilities ... presented with valuable educational information on proper instrument ...
(Date:5/18/2013)... CA (PRWEB) May 18, 2013 John Ravera, ... announced the addition of a new member to his dental ... has worked in the field for over 10 years. She ... with honors, and was elected a member of Sigma Pi ... hygiene profession. Marino enjoys working with patients of all ages, ...
Breaking Medicine News(10 mins):Health News:Best Wireless Home Security System Companies Released by 6Webs.com 2Health News:Ayurveda Training in Mexico Offered by Escuela de Ayurveda de California, a Leading Institution in the West 2Health News:ASDSA Urges Oregon Governor to Sign Under-18 Indoor Tanning Restrictions 2Health News:Spectrum Surgical Attends Society of Gastroenterology Nurses and Associates' (SGNA) 40th Annual Conference in Austin, TX 2Health News:Newport Beach Cosmetic Dentist John Ravera Adds New Member to Dental Team 2
... March 19 Along with the computer age comes the age ... at our computer (whether at work or leisure), we develop a ... blurry vision, stiff shoulders ... sound familiar? Well, you are ... other computer users. The good news is that relief may ...
... solution makes efficient use of shrinking healthcare budgets , ... INC., Multi Vendor Service has announced the launch of ... select ultrasound probes. Enabled by 100 percent repair capabilities, ... exchanges and replacements by maximizing the use of probe ...
... amygdala an almond-shaped structure deep in the human brain ... of Washington have discovered an increased pattern of brain activity ... linked to the social deficits that typically are associated with ... has shown that abnormal growth patterns in the amygdala are ...
... aka "Michael Adams," "Dr. Mitch Michaelson," and "Alberto Gomez,"Arrested ... N.Y., March 19 Jerome Howard Feldman appeared earlier ... wire fraud charges pending in the Northern District of ... in Manila, Philippines, for immigration violations, announced Andrew T. ...
... VNUS Medical Technologies, Inc. (Nasdaq: VNUS ), a ... of venous reflux disease, today announced its plans to present ... Investor Forum, to be held March 24 - 25, 2009, ... The management speaker will be Peter Osborne, Chief Financial Officer ...
... system, expert says , , THURSDAY, March 19 (HealthDay News) -- Though ... chances are it,s not one that can save them when time ... The study in the Annals of Emergency Medicine ... crisis, as is the case with a heart attack or stroke, ...
Cached Medicine News:Health News:The Power of a Tiny Microscopic Plant Found To Reduce Computer Eye Strain 2Health News:MEDRAD Multi Vendor Service Launches TotalRepair(SM) on Select Ultrasound Probes 2Health News:MEDRAD Multi Vendor Service Launches TotalRepair(SM) on Select Ultrasound Probes 3Health News:Heightened level of amygdala activity may cause social deficits in autism 2Health News:Online Organ Transplant Broker Charged With Wire Fraud 2Health News:Online Organ Transplant Broker Charged With Wire Fraud 3Health News:Dearth of Data on Capabilities May Be Hurting ER Care 2
Finesse II electrosurgical generator (100-120 VAC) utilizes a patented design that integrates the electrosurgical generator and smoke evacuation system into a single compact unit....
The Aaron 800-EU is designed and engineered to be the most reliable and durable desiccator available today....
Sabre 180 is a powerful niche generator....
The ExcaliburPlus PC is the most powerful isolated ESU with 10,000 V PTP in spray coag....
Medicine Products: